GraniteShares 2x Long INTC Daily ETF (NASDAQ:INTW) Stock Short Interest Jumps 57.3%
by Michael Walen · The Markets DailyGraniteShares 2x Long INTC Daily ETF (NASDAQ:INTW – Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 15th, there was short interest totaling 3,787,972 shares, a growth of 57.3% from the August 31st total of 2,407,731 shares. Based on an average trading volume of 3,501,292 shares, the short-interest ratio is presently 1.1 days. Currently, 30.1% of the company’s shares are sold short.
Institutional Trading of GraniteShares 2x Long INTC Daily ETF
A hedge fund recently bought a new stake in GraniteShares 2x Long INTC Daily ETF stock. Group One Trading LLC acquired a new position in shares of GraniteShares 2x Long INTC Daily ETF (NASDAQ:INTW – Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 15,188 shares of the company’s stock, valued at approximately $787,000. Group One Trading LLC owned about 0.87% of GraniteShares 2x Long INTC Daily ETF at the end of the most recent reporting period.
GraniteShares 2x Long INTC Daily ETF Stock Performance
NASDAQ:INTW opened at $33.13 on Friday. GraniteShares 2x Long INTC Daily ETF has a 12-month low of $4.47 and a 12-month high of $52.63. The stock’s fifty day simple moving average is $23.28 and its 200-day simple moving average is $26.16.
About GraniteShares 2x Long INTC Daily ETF
The GraniteShares 2x Long INTC Daily ETF (INTW) is an exchange-traded fund that mostly invests in information technology equity. The fund provides 2x leveraged exposure, less fees and expenses, to the daily price movement for shares of Intel Corporation (INTC) stock. INTW was launched on Feb 13, 2025 and is issued by GraniteShares.
See Also
- Five stocks we like better than GraniteShares 2x Long INTC Daily ETF
- Saddle Up: Texas Stock Exchange Ropes In $80 Billion in Listings
- Why Concentra’s Quiet Healthcare Business Keeps Winning
- Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
- Alamos Gold’s 1 Million-Ounce Growth Story Is Hiding in Plain Sight